Key statistics
On Friday, HUTCHMED (China) Ltd (0J7G:LSE) closed at 17.61, -18.11% below its 52-week high of 21.50, set on Oct 23, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 17.61 |
Low | 17.61 |
Bid | -- |
Offer | -- |
Previous close | 17.42 |
Average volume | 169.10 |
---|---|
Shares outstanding | 174.42m |
Free float | 88.83m |
P/E (TTM) | 81.05 |
Market cap | 2.95bn USD |
EPS (TTM) | 0.2162 USD |
Data delayed at least 15 minutes, as of Jul 18 2025 17:53 BST.
More ▼
- HUTCHMED to Announce 2025 Half-Year Results
- HUTCHMED to Announce 2025 Half-Year Financial Results
- Update on Joint Corporate Brokers in London
- Blocklisting Six Monthly Return
- China Approval based on Phase III SACHI Trial
- Total Voting Rights
- HUTCHMED Announces China Approval for ORPATHYS® in Combination with TAGRISSO® for the Treatment of Lung Cancer Patients with MET Amplification After Progression on First-Line EGFR Inhibitor Therapy
- Grant of Share Options and Awards under LTIP
- HUTCHMED and Innovent Announce NDA Acceptance
- HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell Carcinoma
More ▼